Revvity, Inc. (NYSE:RVTY) Shares Acquired by Gotham Asset Management LLC

Gotham Asset Management LLC increased its stake in shares of Revvity, Inc. (NYSE:RVTY) by 37.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 163,756 shares of the company’s stock after acquiring an additional 45,042 shares during the period. Gotham Asset Management LLC’s holdings in Revvity were worth $18,277,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of RVTY. Victory Capital Management Inc. grew its stake in shares of Revvity by 17.4% during the 4th quarter. Victory Capital Management Inc. now owns 70,250 shares of the company’s stock worth $7,841,000 after purchasing an additional 10,390 shares during the period. Contravisory Investment Management Inc. grew its position in Revvity by 1,715.9% during the fourth quarter. Contravisory Investment Management Inc. now owns 69,186 shares of the company’s stock valued at $7,722,000 after buying an additional 65,376 shares during the period. Janney Montgomery Scott LLC increased its holdings in Revvity by 87.0% in the fourth quarter. Janney Montgomery Scott LLC now owns 7,891 shares of the company’s stock valued at $881,000 after buying an additional 3,672 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Revvity by 41.5% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 12,072 shares of the company’s stock worth $1,352,000 after acquiring an additional 3,542 shares during the period. Finally, Tributary Capital Management LLC boosted its stake in shares of Revvity by 45.5% during the 4th quarter. Tributary Capital Management LLC now owns 12,173 shares of the company’s stock worth $1,359,000 after acquiring an additional 3,808 shares in the last quarter. 86.65% of the stock is currently owned by hedge funds and other institutional investors.

Revvity Trading Down 1.8 %

Shares of Revvity stock opened at $91.22 on Friday. The company has a debt-to-equity ratio of 0.41, a current ratio of 3.60 and a quick ratio of 3.03. The stock’s 50 day simple moving average is $100.83 and its 200-day simple moving average is $111.17. The stock has a market cap of $10.96 billion, a P/E ratio of 41.28, a P/E/G ratio of 3.82 and a beta of 1.02. Revvity, Inc. has a 1-year low of $88.53 and a 1-year high of $129.50.

Revvity (NYSE:RVTY) last released its quarterly earnings data on Monday, April 28th. The company reported $1.01 earnings per share for the quarter, topping analysts’ consensus estimates of $0.96 by $0.05. Revvity had a return on equity of 7.68% and a net margin of 9.81%. The company had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. During the same quarter in the previous year, the company posted $0.98 earnings per share. The firm’s revenue for the quarter was up 2.3% compared to the same quarter last year. Analysts predict that Revvity, Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be given a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a yield of 0.31%. The ex-dividend date is Friday, July 18th. Revvity’s payout ratio is currently 11.91%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the company. UBS Group upgraded Revvity from a “neutral” rating to a “buy” rating and cut their price target for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Barclays cut their price objective on Revvity from $140.00 to $110.00 and set an “overweight” rating for the company in a research report on Thursday, April 10th. Raymond James reiterated an “outperform” rating and set a $120.00 target price (down previously from $145.00) on shares of Revvity in a research report on Tuesday, April 29th. Sanford C. Bernstein lowered shares of Revvity from an “outperform” rating to a “market perform” rating and set a $130.00 price target for the company. in a report on Friday, January 10th. Finally, KeyCorp increased their price objective on shares of Revvity from $132.00 to $145.00 and gave the company an “overweight” rating in a report on Monday, February 3rd. Four investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Revvity currently has an average rating of “Moderate Buy” and an average target price of $125.64.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.